BioNexus Gene Lab Corp.

NASDAQ: BGLC · Real-Time Price · USD
5.26
-0.10 (-1.87%)
At close: Aug 15, 2025, 3:59 PM
5.16
-1.90%
After-hours: Aug 15, 2025, 04:50 PM EDT

BioNexus Gene Lab Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-3.12 -3.47 -461.48 485.43
PEG Ratio
0.03 -0.00 3.14 -8.16
PS Ratio
0.52 0.93 15.03 27.30
PB Ratio
0.60 0.95 24.65 50.81
P/FCF Ratio
-2.03 -6.29 330.09 60.82K
P/OCF Ratio
-2.23 -7.01 297.69 39.83K
OCF/S Ratio
-0.23 -0.13 0.05 0.00
Debt / Equity Ratio
0.03 0.01 0.01 0.01
Quick Ratio
3.10 4.24 2.52 2.42
Current Ratio
3.81 4.93 3.00 3.07
Asset Turnover
0.91 0.86 1.25 1.40
Interest Coverage
-74.42 -186.2 -23.33 81.39
Return on Equity
-0.19 -0.27 -0.05 0.10
Return on Assets
-0.15 -0.23 -0.04 0.08
Return on Invested Capital
-0.18 -0.27 -0.05 0.10
Dividend Yield
0.01 n/a 0.00 0.00
Payout Ratio
-0.04 n/a -0.32 0.03
Gross Profit Margin
0.14 0.14 0.12 0.16
Net Profit Margin
-0.17 -0.27 -0.03 0.06
Pretax Profit Margin
-0.17 -0.27 -0.03 0.08
Operating Profit Margin
-0.17 -0.27 -0.03 0.08
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.15 -0.25 -0.02 0.09